March 27, 2020 / 6:07 AM / 2 months ago

BRIEF-FDA Accepts Roche's Drug Application for Xofluza Flu Treatment

March 27 (Reuters) - Roche Holding AG:

* FDA ACCEPTS GENENTECH’S NEW DRUG APPLICATION FOR XOFLUZA FOR THE TREATMENT OF INFLUENZA IN CHILDREN

* GENENTECH, A MEMBER OF ROCHE GROUP (SIX: RO, ROG; OTCQX: RHHBY), TODAY ANNOUNCED THAT U.S. FOOD AND DRUG ADMINISTRATION (FDA) HAS ACCEPTED A NEW DRUG APPLICATION (NDA) AS WELL AS TWO SUPPLEMENTAL NEW DRUG APPLICATIONS (SNDA) FOR XOFLUZA(®) (BALOXAVIR MARBOXIL) Further company coverage: (Reporting by Berlin Speed Desk)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below